Company news
Sernova Biotherapeutics Inc news in 2026
Sernova Biotherapeutics Inc's news releases, calls and decks from 2026, newest first.
Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
October 19, 2026
Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
October 5, 2026
Sernova Biotherapeutics to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference
September 25, 2026
Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference
September 10, 2026
Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
September 8, 2026
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
June 17, 2026
Sernova Biotherapeutics Announces Closing of Recently Approved Financings
April 23, 2026
Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders
April 9, 2026
Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing
March 24, 2026
2026 Q1 MD&A
March 16, 2026
2026 Q1 Financial Statements
March 16, 2026
Voting Instruction Form (VIF) (SVA 2026 VIF)
March 9, 2026
Appointment of Proxyholder (SVA 2026 Proxy)
March 9, 2026
Sernova Biotherapeutics: Combined Circular with Schedules (SVA 2026 Combined Circular w Schedules)
March 9, 2026
Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval
March 4, 2026
Sernova Biotherapeutics Announces Warrant Amendments
February 20, 2026
2025 Q4 MD&A
January 12, 2026
2025 Q4 Financial Statements
January 12, 2026
Decks in 2026
- Merger or Acquisition (2026)
Merger or acquisition · 16 slides · 2026